1. Home
  2. AAPG vs PRCT Comparison

AAPG vs PRCT Comparison

Compare AAPG & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ascentage Pharma Group International American Depository Shares

AAPG

Ascentage Pharma Group International American Depository Shares

N/A

Current Price

$13.05

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Logo PROCEPT BioRobotics Corporation

PRCT

PROCEPT BioRobotics Corporation

N/A

Current Price

$24.55

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AAPG
PRCT
Founded
2009
2009
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
2024
2021

Fundamental Metrics

Financial Performance
Metric
AAPG
PRCT
Price
$13.05
$24.55
Analyst Decision
Strong Buy
Hold
Analyst Count
11
15
Target Price
★ $44.50
$22.75
AVG Volume (30 Days)
5.4K
★ 1.1M
Earning Date
08-19-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 1.71
EPS
★ N/A
N/A
Revenue
N/A
★ $308,054,000.00
Revenue This Year
$17.91
$28.44
Revenue Next Year
$111.96
$20.02
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 37.22
52 Week Low
$13.12
$16.67
52 Week High
$33.09
$38.11

Technical Indicators

Market Signals
Indicator
AAPG
PRCT
Relative Strength Index (RSI) 34.59 69.49
Support Level N/A $20.22
Resistance Level $16.28 $26.41
Average True Range (ATR) 0.44 1.52
MACD -0.17 0.33
Stochastic Oscillator 0.00 97.58

Price Performance

Historical Comparison
AAPG
PRCT

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies and currently has seven drug candidates in pipeline under research. The company's geographical segments include the United States and Mainland China.

About PRCT PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

Share on Social Networks: